In HCC, high TCERG1 expression and shortened survival time and poor prognosis were positively correlated, indicating that TCERG1 could be used as an indicator of disease progression and prognosis in HCC patients. This evidence concerns the gene TCERG1 and hepatocellular carcinoma.